Newark, NJ, United States of America

Rebecca L Joyce

This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca L Joyce. Retrieved from https://idiyas.com/inventor/rebecca-l-joyce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Rebecca L Joyce

Introduction

Rebecca L Joyce is an accomplished inventor based in Newark, NJ. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate HCN channels. With a total of 2 patents to her name, her work has the potential to impact the treatment of various HCN-related disorders.

Latest Patents

Rebecca's latest patents include "Substituted alkylphenols as HCN1 antagonists." These patents describe compounds that modulate HCN channels, which are crucial intermembrane proteins functioning as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. The patents also detail pharmaceutical compositions and kits that incorporate these compounds, along with methods for treating HCN-related disorders, such as pain, by administering the described compounds and compositions.

Career Highlights

Rebecca L Joyce is affiliated with Cornell University, where she continues her research and development efforts. Her work is characterized by a strong focus on innovative solutions to complex medical challenges.

Collaborations

Some of her notable coworkers include Gareth R Tibbs and Peter A Goldstein, who contribute to her research endeavors and collaborative projects.

Conclusion

Rebecca L Joyce stands out as a pioneering inventor in her field, with her patents reflecting her commitment to advancing medical science. Her contributions are poised to make a significant difference in the treatment of HCN-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…